SCHEMBL25578749

SCHEMBL25578749

c1ccc(-c2ccccc2-c2c(-c3ccccc3)cccc2N(c2ccc3oc4ccccc4c3c2)c2cccc3ccccc23)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 8/20 0.34
▸ MAPT P10636 7/20 0.34
▸ HPGD P15428 7/20 0.34
▸ ALDH1A1 P00352 7/20 0.34
▸ HSD17B10 Q99714 4/20 0.34
▸ TSHR P16473 3/20 0.34
▸ ALOX15 P16050 1/20 0.34
▸ CASP1 P29466 1/20 0.34
▸ CASP7 P55210 1/20 0.34
▸ KMT2A Q03164 4/20 0.34
▸ RAB9A P51151 3/20 0.34
▸ NPC1 O15118 2/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ F2 P00734 1/20 0.33
▸ F10 P00742 1/20 0.33
▸ PLG P00747 1/20 0.33
▸ PLAU P00749 1/20 0.33
▸ PLAT P00750 1/20 0.33
▸ PRSS1 P07477 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25580232 0.93 KDM4E (0.33) KDM4EMAPTHPGDALDH1A1HSD17B10
SCHEMBL25578735 0.93 DUSP3 (0.34) KDM4EMAPTHPGDALDH1A1HSD17B10
SCHEMBL25579299 0.92 PLA2G2A (0.36) KDM4EMAPTHPGDALDH1A1HSD17B10
SCHEMBL25580574 0.92 KDM4E (0.34) KDM4EMAPTHPGDALDH1A1HSD17B10
SCHEMBL25578713 0.92 NPC1 (0.36) KDM4EMAPTHPGDALDH1A1KMT2A
SCHEMBL25578962 0.91 MCL1 (0.34) KDM4EMAPTHPGDALDH1A1HSD17B10
SCHEMBL25580865 0.91 KDM4E (0.33) KDM4EMAPTHPGDALDH1A1HSD17B10
SCHEMBL25578930 0.90 MCL1 (0.34) KDM4EMAPTHPGDALDH1A1HSD17B10
SCHEMBL25578879 0.90 KDM4E (0.37) KDM4EMAPTHPGDALDH1A1HSD17B10
SCHEMBL25578725 0.90 KDM4E (0.33) KDM4EMAPTHPGDALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-08 — — US disclosed
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE ESR1, L1CAM, ESR2 KDM4E 2752/4885MAPT 2089/4885HPGD 4709/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback